CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 182,353 enrolled
Drug / intervention
Bio-Rad Platelia Dengue NS1 Ag testdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01226173
NCT01226173N/ACompleted
CompareCT.gov

Study of Bio-Rad Laboratories Platelia Dengue NS1 Ag Assay in Blood Donors.

Bio-Rad Laboratories·observational·Posted Oct 22, 2010·Updated Sep 24, 2012

In Brief

An observational study evaluating Bio-Rad Platelia Dengue NS1 Ag test for Mass Screening. Completed, enrolled 182,353 participants across 2 sites in 2 countries.

Detailed Summary

The purpose of the study is to screen blood donors for the presence of NS1 antigen of the dengue virus at the American Red Cross in Puerto Rico region (and Monroe County, Florida) using the Platelia Dengue NS1 Ag enzyme immunoassay.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMass Screening
CountriesPuerto Rico, United States
CollaboratorsAmerican National Red Cross, Centers for Disease Control and Prevention

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 22, 2010
Enrollment StartMar 1, 2010
Primary CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 15.7 years ago

Interventions

Bio-Rad Platelia Dengue NS1 Ag testdevice

The purpose of the study is to screen blood donors for the presence of dengue NS1 antigen at the ARC in Puerto Rico region using the Bio-Rad Platelia Dengue NS1 Ag test.